In patients with HD (Huntington’s Disease) and R6/2 mice, both choline and phosphocholine levels decrease in the striatum, while glycerophosphocholine increases, suggesting choline metabolism disruption due to GPCPD1 deficiency, which can be ameliorated by citicoline treatment [48]. Here, GPCPD1 is linked to Huntington disease.